Publications by authors named "Aileen Antonio"
Article Synopsis
- Asians in the U.S. face significant healthcare disparities, particularly with increased stroke risk, prompting the development of a tailored stroke education program for underserved Asian American communities in West Michigan.
- Neurology residents and community navigators created culturally appropriate stroke education, conducting sessions over six months while following the Plan-Do-Study-Act model to gather insights on diversity, equity, and inclusion.
- Eighty-six participants from various Asian subgroups attended the program, revealing unique cultural beliefs and systemic barriers to healthcare, highlighting the need for tailored educational efforts to improve stroke care in these populations.
Social Media in Neuro-Ophthalmology: Paradigms, Opportunities, and Strategies.
J Neuroophthalmol
September 2023
Background: Social media (SoMe) is an integral part of life in the 21st century. Its potential for rapid dissemination and amplification of information offers opportunities for neuro-ophthalmologists to have an outsized voice to share expert-level knowledge with the public, other medical professionals, policymakers, and trainees. However, there are also potential pitfalls, because SoMe may spread incorrect or misleading information.
View Article and Find Full Text PDFObjective: Case description of recurrent idiopathic intracranial hypertension (IIH) in a transgender man on gender-affirming hormone therapy.
Methods: Case report.
Results: A 24-year-old transmasculine patient (assigned female at birth), with a body mass index (BMI) of 37.
Background: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in people older than 50 years of age. It causes granulomatous inflammation of medium- to large-sized vessels. Tocilizumab is a recombinant monoclonal antibody directed against interleukin-6 receptors (IL-6R).
View Article and Find Full Text PDFBackground: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in people older than 50 years of age. It causes granulomatous inflammation of medium- to large-sized vessels. Tocilizumab is a recombinant monoclonal antibody directed against interleukin-6 receptors (IL-6R).
View Article and Find Full Text PDF